Robert Stanley Sherwin MD
C. N. H. Long Professor of Medicine (Endocrinology); Section Chief, Endocrinology; Associate Dean for Clinical and Translational Sciences; Director, Yale Center for Clinical Investigation
BiographyRobert S. Sherwin. MD is the C.N.H. Professor of Medicine in the Section of Endocrinology at Yale University School of Medicine in New Haven, CT. He graduated from the Albert Einstein College of Medicine in 1967. After completing his residency in internal medicine at Mount Sinai Hospital (N Y), he moved to the National Institutes of Health to undertake a fellowship in metabolism and diabetes. In 1972 Dr Sherwin moved to Yale University School of Medicine as a postdoctoral fellow and was subsequently appointed to the faculty in 1974. He serves as the Director of the Yale Center for Clinical Investigation as well as the Diabetes Endocrinology Research Center and the JDRF Center for the Study of Hypoglycemia at Yale. His special clinical interests include patients with type 1 diabetes, intensified insulin therapy, complicated type 2 diabetes patients, and hypoglycemia associated with diabetes. Dr Sherwin’s research activities span clinical and basic research and are focused on glucose counterregulation and the immune mechanisms leading to type 1 diabetes mellitus. The studies dealing with counter regulation examine the brain glucose sensing mechanisms mediating the activation of counterregulatory responses and the impact of hypoglycemia and insulin on brain function and metabolism. Research in immunology has led to the isolation of islet-specific T cell clones from diabetic mice that adoptively transfer diabetes and studies of an islet protein linked to islet regeneration. Dr. Sherwin has served as President of the American Diabetes Association and as a member of the FDA Advisory Committee for Endocrinologic and Metabolic Drugs. He is editor of one of the major medical textbooks on diabetes mellitus and wrote the chapter on diabetes for the Cecil Textbook of Medicine. Dr. Sherwin has served as the Chairman of the Medical Science Advisory Board of the JDRF and on the editorial boards of leading diabetes and endocrine journals. He has published over 320 articles in peer-reviewed journals. Dr. Sherwin is the recipient of the American Diabetes Association’s Banting Award for lifetime scientific achievement, the Novartis Award for long-standing achievement in diabetes and 2 MERIT Awards from the NIH.